The effect of COVID-19 on the treatment of opioid use disorders in prisons: a cross-sectional study.

For the latest and updates

Select a page

December 19, 2022

As the COVID-19 pandemic has disrupted the delivery of physical health services everywhere, others involved with criminal formulas and opioid use disorder (OUD) have been disproportionately affected and vulnerable to serious COVID-related illnesses. . The Community and Prison Treatment Programs (CTPs) have temporarily developed protocols to maintain the provision of fitness services while reducing the threat of transmission of COVID-19. This survey examines assessed changes in OUD remedy, telemedicine use, and reintegration assistance facilities among inmates and PTCs participating in the National Institute on Drug Abuse (NIDA), Buprenorphine Opioid Treatments long-acting versus naltrexone in the criminal justice system. – Study of Involved Adults (EXIT-CJS). In December 2020, criminal sites (n = 6; average pre-COVID 2020 monthly census = 3468 more people) and CTPs (n = 7; average pre-COVID 2020 monthly census = 550 patients) that participated in EXIT-CJS terminated a cross-sectional online survey. The survey assessed adjustments before (January-March 2020) and after (April-September 2020) COVID-19 in ODU treatment, telemedicine use, reentry aids, and referral practices. Compared to January-March 2020, part of the criminal sites (n=3) increased the total number of other people who started taking medication for opioid use disorder (MOUD) from April to September 2020, while a third (n = 2) minimized the number of other people initiated. Most CTPs (n=4) reported a trough in new admissions from April to September 2020, with two formulas preventing or postponing MOUD formulas due to COVID-19. All crime sites with pre-COVID telemedicine use (n=5) increased or retained telemedicine use, and all CTPs offering MOUD (n=6) increased telemedicine use. Although the expansion of telemedicine facilities has aided MOUD service delivery, most sites have struggled to provide post-release network support, adding referrals to housing, employment, and transportation facilities. Matrix During the COVID-19 pandemic, this small pattern of CTP sites innovated to continue to deliver the TUO remedy. The expansion of telemedicine facilities was imperative to assist MOUD service delivery. Despite these innovations, the sites have struggled to provide reintegration aids for others on the network. Pre-COVID methods of identifying and interacting with Americans while incarcerated would be less effective since the pandemic. In addition to expanding studies on the most effective telemedicine practices for criminal settings, further studies exploring methods for amplifying rehabilitation of housing and employment aids are imperative. © 2022. The author(s) (s).

Elizabeth C Saunders

Milan F. Satcher

Laura B. Monica

Ryan D McDonald

Sandra Springer

David Farabée

Jan Gryczynski

Amesika Nyaku

Donald Reeves

Lynn E. Kunkel

Alysse M. Schultheis

Robert P. Schwartz

Joshua D. Lee

Lisa A Marsch

Elizabeth Needham Waddell

PubMed

Leave a Comment

Your email address will not be published. Required fields are marked *